Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 2 Open-Label, Multi-Center Study of BMS-986504 as Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT07492680
Title field or adapter rule
{'original_value': 'A Phase 2 Open-Label, Multi-Center Study of BMS-986504 as Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion', 'source_field': 'protocolSection.identificationModule.officialTitle'}
Ingested At
2026-10-31T23:27:23.981768+00:00
Published At
2026-10-06T00:00:00+00:00
Record Updated At
2026-10-06
Source Retrieved At
2026-10-31T22:17:54.613222+00:00
Timestamp Basis
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
Date limitation
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Solid Tumors"]
protocolSection.statusModule.lastUpdatePostDateStruct
{"date": "2026-10-06", "type": "ACTUAL"}
protocolSection.identificationModule.nctId
"NCT07492680"
protocolSection.identificationModule.officialTitle
"A Phase 2 Open-Label, Multi-Center Study of BMS-986504 as Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct
null

Study condition terms

  • Solid Tumors (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

  • {'armGroupLabels': ['Part 1a', 'Part 1b', 'Part 2: Cohort 1', 'Part 2: Cohort 2a', 'Part 2: Cohort 2b', 'Part 2: Cohort 2c', 'Part 2: Cohort 3', 'Part 2: Cohort 4'], 'description': 'Specified dose on specified days', 'name': 'BMS-986504', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Part 2: Cohort 2a', 'Part 2: Cohort 2b', 'Part 2: Cohort 2c'], 'description': 'Specified dose on specified days', 'name': 'Daraxonrasib', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Part 2: Cohort 3'], 'description': 'Specified dose on specified days', 'name': 'Nivolumab + Relatlimab FDC', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Part 2: Cohort 4'], 'description': 'Specified dose on specified days', 'name': 'Temozolomide', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Part 2: Cohort 1'], 'description': 'Specified dose on specified days', 'name': 'Pumitamig', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Part 2: Cohort 1'], 'description': 'Specified dose on specified days', 'name': 'Pemetrexed', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Part 2: Cohort 1'], 'description': 'Specified dose on specified days', 'name': 'Carboplatin', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Part 2: Cohort 1', 'Part 2: Cohort 2c'], 'description': 'Specified dose on specified days', 'name': 'Nab-paclitaxel', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Part 2: Cohort 2c'], 'description': 'Specified dose on specified days', 'name': 'Gemcitabine', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Part 2: Cohort 1'], 'description': 'Specified dose on specified days', 'name': 'Paclitaxel', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

  • BMS-986504 (protocolSection.armsInterventionsModule.interventions[].name)
  • Daraxonrasib (protocolSection.armsInterventionsModule.interventions[].name)
  • Nivolumab + Relatlimab FDC (protocolSection.armsInterventionsModule.interventions[].name)
  • Temozolomide (protocolSection.armsInterventionsModule.interventions[].name)
  • Pumitamig (protocolSection.armsInterventionsModule.interventions[].name)
  • Pemetrexed (protocolSection.armsInterventionsModule.interventions[].name)
  • Carboplatin (protocolSection.armsInterventionsModule.interventions[].name)
  • Nab-paclitaxel (protocolSection.armsInterventionsModule.interventions[].name)
  • Gemcitabine (protocolSection.armsInterventionsModule.interventions[].name)
  • Paclitaxel (protocolSection.armsInterventionsModule.interventions[].name)

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.